These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3516085)
1. Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial. Holcroft JW; Vassar MJ; Weber CJ Ann Surg; 1986 Apr; 203(4):371-8. PubMed ID: 3516085 [TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. Bone RC; Slotman G; Maunder R; Silverman H; Hyers TM; Kerstein MD; Ursprung JJ Chest; 1989 Jul; 96(1):114-9. PubMed ID: 2661155 [TBL] [Abstract][Full Text] [Related]
3. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753 [TBL] [Abstract][Full Text] [Related]
4. Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group. Silverman HJ; Slotman G; Bone RC; Maunder R; Hyers TM; Kerstein MD; Ursprung JJ Chest; 1990 Aug; 98(2):405-10. PubMed ID: 2198140 [TBL] [Abstract][Full Text] [Related]
5. Physiologic effects and side effects of prostaglandin E1 in the adult respiratory distress syndrome. Russell JA; Ronco JJ; Dodek PM Chest; 1990 Mar; 97(3):684-92. PubMed ID: 2306970 [TBL] [Abstract][Full Text] [Related]
6. The effects of prostaglandin E1 on non-pulmonary organ function during clinical acute respiratory failure. The Prostaglandin E1 Study Group. Slotman GJ; Kerstein MD; Bone RC; Silverman H; Maunder R; Hyers TM; Ursprung JJ J Trauma; 1992 Apr; 32(4):480-8; discussion 488-9. PubMed ID: 1569622 [TBL] [Abstract][Full Text] [Related]
7. Functional and metabolic activity of polymorphonuclear leukocytes from patients with adult respiratory distress syndrome: results of a randomized double-blind placebo-controlled study on the activity of prostaglandin E1. Rossignon MD; Khayat D; Royer C; Rouby JJ; Jacquillat C; Viars P Anesthesiology; 1990 Feb; 72(2):276-81. PubMed ID: 2405741 [TBL] [Abstract][Full Text] [Related]
8. Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. Abraham E; Park YC; Covington P; Conrad SA; Schwartz M Crit Care Med; 1996 Jan; 24(1):10-5. PubMed ID: 8565513 [TBL] [Abstract][Full Text] [Related]
13. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers. Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Cox JW; Andreadis NA; Bone RC; Maunder RJ; Pullen RH; Ursprung JJ; Vassar MJ Am Rev Respir Dis; 1988 Jan; 137(1):5-12. PubMed ID: 3337471 [TBL] [Abstract][Full Text] [Related]
15. A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome. Mohrland JS; Porter JM; Smith EA; Belch J; Simms MH Ann Rheum Dis; 1985 Nov; 44(11):754-60. PubMed ID: 3904643 [TBL] [Abstract][Full Text] [Related]
16. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders. Mizushima Y; Shiokawa Y; Homma M; Kashiwazaki S; Ichikawa Y; Hashimoto H; Sakuma A J Rheumatol; 1987 Feb; 14(1):97-101. PubMed ID: 3553591 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting. Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805 [TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome. Putensen C; Hörmann C; Kleinsasser A; Putensen-Himmer G Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1743-7. PubMed ID: 9620900 [TBL] [Abstract][Full Text] [Related]